Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease
From MaRDI portal
Publication:3545654
Recommendations
- scientific article; zbMATH DE number 854843
- Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women
- The evaluation of disease prevention and treatment using simulation models
- Choice of modelling technique for evaluating health care interventions
- Comparing strategies to prevent stroke and ischemic heart disease in the Tunisian population: Markov modeling approach using a comprehensive sensitivity analysis algorithm
Cited in
(5)- scientific article; zbMATH DE number 854843 (Why is no real title available?)
- How many AEDs in which region? An economic decision model for the Austrian red cross
- Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden
- Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women
- Comparing strategies to prevent stroke and ischemic heart disease in the Tunisian population: Markov modeling approach using a comprehensive sensitivity analysis algorithm
This page was built for publication: Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3545654)